Macrophage-specific gene expression: Current paradigms and future challenges

International Journal of Hematology

Volumn 76, Issue 1, 2002, Pages 6-15

  Greaves, David R ^a   Gordon, Siamon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Locus control regions; Macrophages; Promoter analysis; PU.1; Transcription factors; Transgenic animals

Indexed keywords

ANTIINFLAMMATORY AGENT; CHLORDANE; RANTES;

C FES GENE; GENE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; MACROPHAGE; MACROPHAGE FUNCTION; NONHUMAN; REVIEW; SPI 1 GENE; ANIMAL; GENETIC TRANSCRIPTION; METABOLISM;

ANIMALS; GENE EXPRESSION; HUMANS; MACROPHAGES; TRANSCRIPTION, GENETIC;

EID: 0036635837     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982713     Document Type: Review

References (78)

1. Baltimore D. Our genome unveiled. Nature. 2001;409:814-816.
2. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-127.
3. Lin HH, Stacey M, Hamann J, Gordon S, McKnight AJ. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97. Genomics. 2000;67:188-200.
4. Dillon N, Sabbattini P. Functional gene expression domains: defining the functional unit of eukaryotic gene regulation. Bioessays. 2000;22:657-665.
5. Verrijzer CP, Tjian R. TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem Sci. 1996;21:338-342.
6. Berk AJ.TBP-like factors come into focus. Cell. 2000;103:5-8.
7. Javahery R, Khachi A, Lo K, Zenzie-Gregory B, Smale ST. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Blol. 1994;14:116-127.
8. Smale ST, Baltimore D. The "initiator" as a transcription control element. Cell. 1989;57:103-113.
9. Suzuki Y, Tsunoda T, Sese J, et al. Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res. 2001;11:677-684.
10. Clarke S, Gordon S. Myeloid-specific gene expression. J Leukoc Biol. 1998;63:153-168.
11. Tenen DG, Hromas R, Licht JD, Zhang DE. Transcription factors, normal myeloid development, and leukemia. Blood. 1997;90:489-519.
12. Ross IL, Yue X, Ostrowski MC, Hume DA. Interaction between PU.1 and another Ets family transcription factor promotes macrophage-specific basal transcription initiation. J Biol Chem. 1998;273:6662-6669.
13. McKnight SL, Gavis ER. Expression of the herpes thymidine kinase gene in Xenopus laevis oocytes: an assay for the study of deletion mutants constructed in vitro. Nucleic Acids Res. 1980;8:5931-5948.
14. Myers RM, Tilly K, Maniatis T. Fine structure genetic analysis of a beta-globin promoter. Science. 1986;232:613-618.
15. Kadonaga JT, Carner KR, Masiarz FR,Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 1987;51:1079-1090.
16. Kadonaga JT, Courey AJ, Ladika J, Tjian R. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science. 1988;242:1566-1570.
17. Lemon B, Tjian R. Orchestrated response: a symphony of transcription factors for gene control. Genes Dev. 2000;14:2551-2569.
18. Smale ST. Core promoters: active contributors to combinatorial gene regulation. Genes Dev. 2001;15:2503-2508.
19. Banerji J, Rusconi S, Schaffner W. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell. 1981;27:299-308.
20. Dorsch-Hasler K, Keil GM, Weber F, Jasin M, Schaffner W, Koszinowski UH. A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A. 1985;82:8325-8329.
21. Schaffner W. Gene regulation: a hit-and-run mechanism for transcriptional activation? Nature. 1988;336:427-428.
22. Fry CJ, Peterson CL. Chromatin remodeling enzymes: who's on first? Curr Biol. 2001;11:R185-R197.
23. Rosenfeld MG, Glass CK. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem. 2001;276:36865-3688.
24. Kollias G, Hurst J, deBoer E, Grosveld F. The human beta-globin gene contains a downstream developmental specific enhancer. Nucleic Acids Res. 1987;15:5739-5747.
25. Grosveld F, van Assendelft GB, Greaves DR, Kollias G. Position-independent, high-level expression of the human beta globin gene in transgenic mice. Cell. 1987;51:975-985.
26. Talbot DJ, Collis P, Antoniou M, Vidal M, Grosveld F, Greaves DR. A dominant control region from the human beta-globin locus conferring integration site- independent gene expression. Nature. 1989;338:352-355.
27. Blom van Assendelft G, Hanscombe O, Grosveld F, Greaves DR. The beta-globin dominant control region activates homologous and heterologous promoters in a tissue-specific manner. Cell. 1989;56:969-977.
28. Orkin SH. Globin gene regulation and switching: circa 1990. Cell. 1990;63:665-672.
29. Greaves DR, Wilson FD, Lang G, Kioussis D. Human CD2 3′ flanking sequences confer high-level, T-cell specific, position independent gene expression in transgenic mice. Cell. 1989;56:979-986.
30. Diaz P, Cado D, Winoto A. A locus control region in the T cell receptor alpha/delta locus. Immunity. 1994;1:207-217.
31. Madisen L, Groudine M. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev. 1994;8:2212-2226.
32. Sabbattini P, Georgiou A, Sinclair C, Dillon N. Analysis of mice with single and multiple copies of transgenes reveals a novel arrangement for the lambda5-VpreB1 locus control region. Mol Cell Biol. 1999;19:671-679.
33. Aronow BJ, Silbiger RN, Dusing MR, et al. Functional analysis of the human adenosine deaminase gene thymic regulatory region and its ability to generate position-independent transgene expression. Mol Cell Biol. 1992;12:4170-4185.
34. Grosveld F. Activation by locus control regions? Curr Opin Genet Dev. 1999;9:152-157.
35. Festenstein R, Kioussis D. Locus control regions and epigenetic chromatin modifiers. Curr Opin Genet Dev. 2000;10:199-203.
36. Engel JD, Tanimoto K. Looping, linking, and chromatin activity: new insights into beta-globin locus regulation. Cell. 2000;100:499-502.
37. Greer P, Maltby V, Rossant J, Bernstein A, Pawson T. Myeloid expression of the human c-fps/c-fes proto-oncogene in transgenic mice. Mol Cell Biol. 1990;10:2521-2527.
38. Heydemann A, Juang G, Hennessy K, Parmacek MS, Simon MC. The myeloid cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Mol Cell Biol. 1996;16:1676-1686.
39. Heydemann A, Boehmler JH, Simon MC. Expression of two myeloid cell-specific genes requires the novel transcription factor, c-fes expression factor. J Biol Chem. 1997;272:29527-29537.
40. Heydemann A, Warming S, Clendenin C, Sigrist K, Hjorth JP, Simon MC. A minimal c-fes cassette directs myeloid-specific expression in transgenic mice. Blood. 2000;96:3040-3048.
41. Chen HM, Zhang P, Voso MT, et al. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood. 1995;85:2918-2928.
42. van Dijk TB, Caldenhoven E, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP. The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene. Blood. 1998;91:2126-2132.
43. Henkel GW, McKercher SR, Yamamoto H, Anderson KL, Oshima RG, Maki RA. PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells. Blood. 1996;88:2917-2926.
44. Anderson KL, Perkin H, Surh CD, Venturini S, Maki RA, Torbett BE. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol. 2000;164:1855-1861.
45. Simon MC. PU.1 and hematopoiesis: lessons learned from gene targeting experiments. Semin Immunol. 1998;10:111-118.
46. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994;265:1573-1577.
47. McKercher SR, Torbett BE, Anderson KL, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996;15:5647-5658.
48. Zhang P, Zhang X, Iwama A, et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood. 2000;96:2641-2648.
49. Chen H, Ray-Gallet D, Zhang P, et al. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene. 1995;11:1549-1560.
50. Chen H, Zhang P, Radomska HS, Hetherington CJ, Zhang DE, Tenen DG. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter. J Biol Chem. 1996;271:15743-15752.
51. Li Y, Okuno Y, Zhang P, et al. Regulation of the PU.1 gene by distal elements. Blood. 2001;98:2958-2965.
52. Philipsen S, Talbot D, Fraser P, Grosveld F. The beta-globin dominant control region: hypersensitive site 2. EMBO J. 1990;9:2159-2167.
53. Talbot D, Philipsen S, Fraser P, Grosveld F. Detailed analysis of the site 3 region of the human beta-globin dominant control region. EMBO J. 1990;9:2169-2177.
54. Schall TJ, Jongstra J, Dyer BJ, et al. A human T cell-specific molecule is a member of a new gene family. J Immunol. 1988;141:1018-1025.
55. Greaves DR, Schall TJ. Chemokines and myeloid cell recruitment. Microbes Infect. 2000;2:331-336.
56. Marfaing-Koka A, Devergne O, Gorgone G, et al. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and 1L-13. J Immunol. 1995;154:1870-1878.
57. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts: differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem. 1993;268:5834-5839.
58. Zhang L, Redington AE, Holgate ST. RANTES: a novel mediator of allergic inflammation? Clin Exp Allergy. 1994;24:899-904.
59. Ehrt S, Schnappinger D, Bekiranov S, et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med. 2001;194:1123-1140.
60. Song A, Nikolcheva T, Krensky AM. Transcriptional regulation of RANTES expression in T lymphocytes. Immunol Rev. 2000;177:236-245.
61. Boehlk S, Fessele S, Mojaat A, et al. ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells. Eur J Immunol. 2000;30:1102-1112.
62. Fessele S, Boehlk S, Mojaat A et al. Molecular and in silico characterization of a promoter module and C/EBP element that mediate LPS-induced RANTES/CCL5 expression in monocytic cells. FASEB J. 2001;15:577-579.
63. Fessele S, Maier H, Zischek C, Nelson PJ, Werner T. Regulatory context is a crucial part of gene function. Trends Genet. 2002;18:60-63.
64. Pulford KA, Sipos A, Cordell JL, Stross WP, Mason DY. Distribution of the CD68 macrophage/myeloid associated antigen. Int Immunol. 1990;2:973-980.
65. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood. 1993;81:1607-1613.
66. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1996;93:14833-14838.
67. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A. 1995;92:9580-9584.
68. Jones E, Quinn CM, See CG, et al. The linked human elongation initiation factor 4A1 (EIF4A1) and CD68 genes map to chromosome 17p13. Genomics. 1998;53:248-250.
69. Miyashita A, Shimizu N, Endo N, et al. Five different genes, Eif4a1, Cd68, Supl15H and Fxr2h, are clustered in a 40 kb region of mouse chromosome 11. Gene. 1999;237:53-60.
70. Greaves DR, Quinn CM, Seldin MF, Gordon S. Functional comparison of the murine macrosialin and human CD68 promoters in macrophage and non macrophage cell lines. Genomics. 1998;54:165-168.
71. Li AC, Guidez FR, Collier JG,Glass CK.The macrosialin promoter directs high levels of transcriptional activity in macrophages dependent on combinatorial interactions between PU.1 and c-Jun. J Biol Chem. 1998;273:5389-5399.
72. Gough PJ, Gordon S, Greaves DR. The use of human CD68 transcriptional regulatory sequences to direct high level expression of scavenger receptor SR-A in macrophages in vitro and in vivo. Immunology. 2001;103:351-361.
73. Lang R, Rutschman RL, Greaves DR, Murray PJ. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J Immunol. 2002;168:3402-3411.
74. Hashimoto S, Suzuki T, Dong HY, et al. Serial analysis of gene expression in human monocytes and macrophages. Blood. 1999;94:837-844.
75. Hashimoto SI, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood. 2000;96:2206-2214.
76. Huang Q, Liu D, Majewski P et al. The plasticity of dendritic cell responses to pathogens and their components. Science. 2001;294:870-875.
77. Shiffman D, Mikita T, Tai JT, et al. Large scale gene expression analysis of cholesterol-loaded macrophages. J Biol Chem. 2000;275:37324-37332.
78. DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 2000;288:1439-1441.